An FDA-approved synthetic THC significantly reduces agitation in Alzheimer's patients, improving treatment outcomes and ...

An FDA-approved synthetic version of THC (the main ingredient in cannabis) reduces agitation in patients with Alzheimer's ...

Patients tolerated synthetic THC (dronabinol) well, without the adverse effects commonly associated with existing Alzheimer's ...

The rate of antipsychotic drug use in nursing homes has remained stubbornly high. Experts are concerned about misuse.

In a study led by the Johns Hopkins University School of Medicine and Tufts University School of Medicine, researchers show ...

A synthetic form of the active ingredient in cannabis helps reduce agitation in people with Alzheimer's, new research shows.

Barbara was very close to her mom, considering her a great motivator who made Barbara believe she could do anything she ...

The new study included 75 outpatients with Alzheimer's dementia ... treat agitation in people with dementias. "While further analyses are needed to better understand predictors of treatment ...

Agitation is one of the most distressing symptoms of Alzheimer's dementia, and we are pleased to make positive strides forward in treatment of these patients." Paul Rosenberg, M.D., professor of ...

Kathy Richards, PhD, RN, FAAN, FAASM, of the University of Texas at Austin School of Nursing, presents cases of sleep disturbances in older adults at GAPNA 2024.